BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Bisoprolol Fumarate And Hydrochlorothiazide patents expire, and what generic alternatives are available?
Bisoprolol Fumarate And Hydrochlorothiazide is a drug marketed by Actavis Elizabeth, Apothecon, Cadila, Chartwell Rx, Edenbridge Pharms, Epic Pharma Llc, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva, Unichem, and Watson Labs Teva. and is included in thirteen NDAs.
The generic ingredient in BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE is bisoprolol fumarate; hydrochlorothiazide. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bisoprolol Fumarate And Hydrochlorothiazide
A generic version of BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE was approved as bisoprolol fumarate; hydrochlorothiazide by EPIC PHARMA LLC on September 25th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE?
Summary for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 9 |
What excipients (inactive ingredients) are in BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE? | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE excipients list |
DailyMed Link: | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE at DailyMed |
Pharmacology for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Drug Class | Thiazide Diuretic beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Increased Diuresis |